However, the unquestionable advantage of this study was the careful selection (in terms of inclusion and exclusion criteria) of the experimental and control groups, and the fact that it is the first study to evaluate the antioxidant barrier and oxidative damage in the saliva of patients with BRCA1-mediated and BRCA1-unmediated breast cancer. This evidence concerns the gene BRCA1 and breast carcinoma.